Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease.

Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. Abstract Text:

ABSTRACT: BACKGROUND: Experimental autoimmune encephalomyelitis is a widely used animal model to understand not only multiple sclerosis but also basic principles of immunity. The disease is scored typically by observing signs of paralysis, which do not always correspond with pathological changes. METHODS: Experimental autoimmune encephalomyelitis was induced in transgenic mice expressing an injury responsive luciferase reporter in astrocytes (GFAP-luc). Bioluminescence in the brain and spinal cord was measured non-invasively in living mice. Mice were sacrificed at different time points to evaluate clinical and pathological changes. The correlation between bioluminescence and clinical and pathological EAE was statistically analyzed by Pearson correlation analysis. RESULTS: Bioluminescence from the brain and spinal cord correlates strongly with severity of clinical disease and a number of pathological changes in the brain in EAE. Bioluminescence at early time points also predicts severity of disease. CONCLUSION: These results highlight the potential use of bioluminescence imaging to monitor neuroinflammation for rapid drug screening and immunological studies in EAE and suggest that similar approaches could be applied to other animal models of autoimmune and inflammatory disorders.

Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of neuroinflammation

VOLUME: 5

Page Numbers: 6

Journal Abbreviation:

ISSN: 1742-2094

DAY: 1

MONTH: 02

YEAR: 2008

Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101222974

Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease.

AFFILIATION: Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California 94305, USA. twc@stanford.edu.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Neuroinflammation

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease Related Publications

• A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models.
• Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration.
• Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease.
• Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.
• Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis.
• Immune cells may fend off Alzheimer disease.
• Microglia-a wrench in the running wheel?
• Systemic and acquired immune responses in Alzheimer's disease.